Efficacy of CDK4/6 Inhibitors Plus Endocrine Therapy vs Placebo Plus Endocrine Therapy for HR+/HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
CDK4/6 inhibitors plus endocrine therapy vs. placebo plus endocrine therapy for HR+/HER2- advanced breast cancer: a phase III RCTs based meta-analysis
BMC Cancer 2024 Aug 21;24(1)1031, C Luo, K Yu, X Luo, T Lian, X Liu, W Xu, Z JinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.